IDBI Healthcare Fund Direct Growth
IDBI Healthcare Fund Direct Growth

IDBI Healthcare Fund Direct Growth

Compare
Equity
Direct
Sector - Healthcare

NAV: ₹ 17.3 as on 08-02-2023

Fund Performance
zero opening, trading, fund transfer fee
20 people have invested ₹ 67.7K in mutual fund in the last three months

Fund Insights

Insights icon

In the last 1 year, DSP Healthcare Fund Direct Growth has given 2.32% return, outperforming this fund by 10.47%

Insights icon

In the last 3 years, DSP Healthcare Fund Direct Growth has given 24.09% return, outperforming this fund by 9.19% per annum

Insights icon

This fund has one of the lowest expense ratio in the category (sector - healthcare). Its expense ratio is 1.24% which is lower than the category average expense ratio of 1.59%

INDmoney Rank

Powered by IND quant engine
IND ranking is not available for this fund.
Pros
Hold on while we find any good points for this fund.
Cons
3Y returns in the bottom 25% of the category

Fund Performance as on (19-Jan-23)

Return
1M
3M
6M
1Y
3Y
This Fund
-3.1%
-6.7%
-5.6%
-8.1%
14.9%
Benchmark
-2.3%
2.2%
9.6%
-0.5%
15%
Category
-1.3%
-4.8%
-1.8%
-4.8%
18.7%
About the Fund

IDBI Healthcare Fund Direct Growth is an equity fund. This fund was started on  28 February, 2019. The fund is managed by Alok Ranjan. The fund could potentially beat inflation in the long-run.

Key parameters

1) IDBI Healthcare Fund Direct Growth has a NAV of 17.25 as on 08-02-2023.

2) IDBI Healthcare Fund Direct Growth has 52 Cr worth of assets under management (AUM) as on 31-12-2022 and is less than category average.

3) The fund has an expense ratio 1.24 %.

Fund Overview

Expense ratio
Expense ratio
1.24%
Benchmark
Benchmark
S&P BSE Healthcare PR
AUM
AUM
₹52 Cr
Inception Date
Inception Date
28 February, 2019
Min Lumpsum/SIP
Min Lumpsum/SIP
₹5000/₹500
Exit Load
Exit Load
1%
Lock In
Lock In
No Lock-in
TurnOver
TurnOver
723.01%

Fund Distribution as on (31-Dec-22)

  • Equity 97%
  • Debt & Cash 3%
Size breakup
Large cap
59.8%
Mid cap
24.2%
Small cap
13%

Sector Allocation

Dec'22

Nov'22

Oct'22

Health

93.5%

Basic Materials

3.8%

Financial Services

2.7%

Top Holdings as on (31-Dec-22)

  • Equity
  • Debt & Cash
Equity Holdings23
Debt Holdings1

What changed

in last one month
  • Scheme
  • Portfolio
AUM decreased by 3.7 Cr in last 1M
Dec'22 return underperformed benchmark

Change in AUM

Dec'22
₹ 54.3 Cr
Nov'22
₹ 58.1 Cr
Oct'22
₹ 60.6 Cr

Fund Returns vs Benchmark

Jan'23
1.48%
5.37%
Dec'22
-0.11%
2.63%
Nov'22
1.48%
5.37%
Fund Return
Benchmark Return

Concentration Analysis as on (31-Dec-22)

Fund
Dec'22
Nov'22
Oct'22
No of Holdings
24
25
25
Top 5 Company Concentration
52.9%
52.6%
50.3%
Company having highest exposure
Sun Pharmaceuticals Industries Ltd (16.6%)
Sun Pharmaceuticals Industries Ltd (17.2%)
Sun Pharmaceuticals Industries Ltd (16.1%)
No of Sectors
4
4
4
Top 5 Sectors Concentration
100%
100%
100%
Sector having highest exposure
Health (90.7%)
Health (91.4%)
Health (88%)

Fund Manager

Alok Ranjan

Alok Ranjan

Fund Manager of IDBI Healthcare Fund Direct Growth, since 16 August 2021

AMC details

Fund House
IDBI Asset Management Limited
Total Schemes
Total AUM
₹3.78K Cr
as on 31-Dec-2022
Address
IDBI Asset Management Ltd.,5th floor, Mafatlal Centre,,Nariman Point,
Phone
+912266442800
Email
contactus@idbimutual.co.in

Fund Highlights

Risk meter
pointer

Very High Risk

Investors understand that their principal will be at Very High Risk
About the fund

About the fund

This fund has delivered an average annual returns of 14.82% since inception which is less than its category average return of 15.3%
Fund Allocations

Fund Allocations

This fund has an allocation of 97.03% in Equity, 0% in Debt and 2.97% in Cash related instruments
AUM size ₹52 Cr

AUM size ₹52 Cr

This fund has AUM of ₹52 Cr which is less than its category average of ₹ 1301 Cr
Expense Ratio 1.24%

Expense Ratio 1.24%

This fund has an expense ratio of 1.24% which is less than its category average expense ratio of 1.54%

Frequently Asked Questions

The current NAV of IDBI Healthcare Fund Direct Growth is 17.03 as on 07-Feb-2023.
Existing (Absolute + CAGR)
IDBI Healthcare Fund Direct Growth
Absolute Returns
CAGR Returns
1 Month Returns
-4.38%
-4.38%
6 Month Returns
-6.63%
-6.63%
1 Year Returns
-9.12%
-9.12%
3 Years Returns
49.78%
14.42%
5 Years Returns
0%
0%
With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.
1.24 as on January 2023
54 Cr as on January 2023
Sun Pharmaceuticals Industries Ltd(16.58%),Dr Reddy's Laboratories Ltd(10.06%),Divi's Laboratories Ltd(9.8%),Cipla Ltd(9.11%),Apollo Hospitals Enterprise Ltd(7.32%) as on January 2023
Health(90.69%),Basic Materials(3.72%),Cash Equivalent(2.97%) as on January 2023
The alpha ratio for the IDBI Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
IDBI Healthcare Fund Direct Growth
-1.29
-0.91
-
As on January 2023
The alpha for IDBI Healthcare Fund Direct Growth is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the IDBI Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
IDBI Healthcare Fund Direct Growth
0.93
0.92
-
As on January 2023
The Beta for IDBI Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the IDBI Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
IDBI Healthcare Fund Direct Growth
-0.88
0.6
-
As on January 2023
The sharpe ratio for IDBI Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the IDBI Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
IDBI Healthcare Fund Direct Growth
12.47
20.86
-
As on January 2023
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 1.32 as on January 2023. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Alok Ranjan is the fund manager of IDBI Healthcare Fund Direct Growth
The Exit load of IDBI Healthcare Fund Direct Growth is 1%

Mutual Fund execution provided by

Technology facilitation Services provided by Finzoom Investment Advisors Pvt. Ltd. - Advisory unit. SEBI Registered Investment Advisor: INA100012190 | BASL Registration No. 1154 | BSE StarMF Platform code: 24801

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme related documents carefully. Past performance is not indicative of future returns.